Cargando…
5-Fluorotryptamine is a partial agonist at 5-HT(3) receptors, and reveals that size and electronegativity at the 5 position of tryptamine are critical for efficient receptor function
Antagonists, but not agonists, of the 5-HT(3) receptor are useful therapeutic agents, and it is possible that partial agonists may also be potentially useful in the clinic. Here we show that 5-fluorotryptamine (5-FT) is a partial agonist at both 5-HT(3A) and 5-HT(3AB) receptors with an R(max) (I(max...
Autores principales: | Bower, Kiowa S., Price, Kerry L., Sturdee, Laura E.C., Dayrell, Mariza, Dougherty, Dennis A., Lummis, Sarah C.R. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2649378/ https://www.ncbi.nlm.nih.gov/pubmed/18082160 http://dx.doi.org/10.1016/j.ejphar.2007.11.014 |
Ejemplares similares
-
A Hydrogen Bond in Loop A Is Critical for the Binding and Function of the 5-HT(3) Receptor
por: Price, Kerry L., et al.
Publicado: (2008) -
Agonists and antagonists induce different palonosetron dissociation rates in 5-HT(3)A and 5-HT(3)AB receptors()
por: Lummis, Sarah C.R., et al.
Publicado: (2013) -
Varenicline Interactions
at the 5-HT(3) Receptor Ligand Binding Site are Revealed
by 5-HTBP
por: Price, Kerry L., et al.
Publicado: (2015) -
Novel Oleanolic Acid-Tryptamine and -Fluorotryptamine Amides: From Adaptogens to Agents Targeting In Vitro Cell Apoptosis
por: Bildziukevich, Uladzimir, et al.
Publicado: (2021) -
5-HT(3) Receptors
por: Lummis, Sarah C. R.
Publicado: (2012)